Biogen to eliminate 1,000 jobs in further cost cuts
Cognizant, Gilead extend service agreement worth $800M
Astellas notches another protein degrader pact with $21M upfront for PeptiDream
Twitter’s rebrand into X spurs ‘healthy skepticism’ among medical marketers
*please scroll down for all the latest news*
